Analysis: Film-Maker Fujifilm To Enter Japan Drug Business with Toyama Chemical Acquisition
This article was originally published in PharmAsia News
Executive Summary
Fujifilm Holdings' bid to buy Toyama Chemical signals a move by companies with technologies beneficial to drug making to enter the pharmaceutical market. Ajinomoto, in the seasoning and food business, relies on fermentation technologies for its amino acid-based drugs, and Toray Industries applies biotechnology and nanotechnology to help develop drugs with long-lasting effects. Japan Pharmaceutical Manufacturers Association President Hatsuo Aoki said his industry expects to see an increase in mergers and acquisitions centered on certain technologies rather than company size. (Click here for more - a subscription may be required